Zentalis Pharmaceuticals, Inc.
ZNTL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001725160
In the last 90 days, Zentalis Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 114 institutions reported holding it in 13F filings for Q2 2026, worth $228.9M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Zentalis Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 132
- −9 vs. Q4 2024
- Shares held
- 58.5M
- −5.33M (−8.4%) vs. Q4 2024
- Total value
- $92.9M
- −$100.3M (−51.9%) vs. Q4 2024
- New holders
- 18
- 42 more added
- Sold out
- 27
- 49 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZNTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 114 | $228.9M |
| Q1 2026 | 102 | $101.7M |
| Q4 2025 | 86 | $54.9M |
| Q3 2025 | 99 | $79.7M |
| Q2 2025 | 117 | $64.5M |
| Q1 2025 | 132 | $92.9M |
| Q4 2024 | 142 | $195.2M |
| Q3 2024 | 136 | $261.2M |
| Q2 2024 | 145 | $314.3M |
| Q1 2024 | 142 | $1.34B |
| Q4 2023 | 120 | $1.23B |
| Q3 2023 | 137 | $1.61B |
| Q2 2023 | 134 | $2.32B |
| Q1 2023 | 110 | $1.15B |
| Q4 2022 | 106 | $1.30B |
| Q3 2022 | 121 | $1.27B |
| Q2 2022 | 122 | $1.64B |
| Q1 2022 | 128 | $2.05B |
| Q4 2021 | 139 | $3.61B |
| Q3 2021 | 116 | $2.75B |
| Q2 2021 | 120 | $2.13B |
| Q1 2021 | 95 | $1.58B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Zentalis Pharmaceuticals, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Dimensional Fund Advisors LP | 447,400 | $711.5K | 0.00% | −57,606−11.4% | Reduced |
| Goldman Sachs Group Inc | 456,393 | $725.7K | 0.00% | −461,714−50.3% | Reduced |
| Northern Trust Corp | 462,303 | $735.1K | 0.00% | −22,435−4.6% | Reduced |
| Charles Schwab Investment Management Inc | 486,499 | $773.5K | 0.00% | −10,863−2.2% | Reduced |
| 5AM Venture Management, LLC | 490,000 | $779.1K | 0.29% | 00.0% | Unchanged |
| Nuveen, LLC | 507,527 | $807.0K | 0.00% | +507,527 | New |
| Woodline Partners LP | 530,582 | $843.6K | 0.01% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 541,975 | $862.0K | 0.08% | +397,805+275.9% | Added |
| Two Sigma Investments, LP | 549,334 | $873.4K | 0.00% | −67,466−10.9% | Reduced |
| Peapod Lane Capital LLC | 558,418 | $887.9K | 1.00% | +558,418 | New |
| AQR Capital Management LLC | 619,330 | $984.7K | 0.00% | +396,233+177.6% | Added |
| JPMorgan Chase & Co | 746,476 | $1.19M | 0.00% | −113,234−13.2% | Reduced |
| Federated Hermes, Inc. | 752,517 | $1.20M | 0.00% | +258,535+52.3% | Added |
| Renaissance Technologies LLC | 826,041 | $1.31M | 0.00% | +286,696+53.2% | Added |
| Two Sigma Advisers, LP | 842,600 | $1.34M | 0.00% | −47,100−5.3% | Reduced |
| Pfizer Inc | 953,834 | $1.52M | 0.30% | 00.0% | Unchanged |
| Tybourne Capital Management (HK) Ltd | 961,486 | $1.53M | 6.49% | 00.0% | Unchanged |
| Morgan Stanley | 1,093,958 | $1.74M | 0.00% | −619,230−36.1% | Reduced |
| D. E. Shaw & Co., Inc. | 1,117,777 | $1.78M | 0.00% | −121,682−9.8% | Reduced |
| Bank of America Corp | 1,130,092 | $1.80M | 0.00% | +914,093+423.2% | Added |
| Primecap Management Co | 1,264,620 | $2.01M | 0.00% | −256,010−16.8% | Reduced |
| State Street Corp | 1,319,785 | $2.10M | 0.00% | +30,800+2.4% | Added |
| Geode Capital Management, LLC | 1,355,669 | $2.16M | 0.00% | +42,705+3.3% | Added |
| Tang Capital Management LLC | 1,500,000 | $2.38M | 0.13% | +1,500,000 | New |
| Almitas Capital LLC | 1,710,921 | $2.72M | 0.90% | +84,025+5.2% | Added |
| Opaleye Management Inc. | 1,985,000 | $3.16M | 0.70% | +217,500+12.3% | Added |
| Decheng Capital LLC | 2,019,762 | $3.21M | 0.90% | −318,333−13.6% | Reduced |
| Acadian Asset Management LLC | 2,674,035 | $4.24M | 0.01% | +1,606,802+150.6% | Added |
| Millennium Management LLC | 3,069,514 | $4.88M | 0.00% | +2,111,951+220.6% | Added |
| Vanguard Group Inc | 3,260,612 | $5.18M | 0.00% | −10,628−0.3% | Reduced |
| BlackRock, Inc. | 4,229,497 | $6.72M | 0.00% | −8,592−0.2% | Reduced |
| Matrix Capital Management Company, LP | 13,959,973 | $22.2M | 6.39% | 00.0% | Unchanged |
| Proequities, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −4,475,054−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −1,106,851−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −1,050,000−100.0% | Sold out |
| Boxer Capital Management, LLC | 0 | $0 | 0.00% | −450,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −140,394−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −106,748−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −106,080−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −89,012−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −59,805−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −57,592−100.0% | Sold out |
| Values First Advisors, Inc. | 0 | $0 | 0.00% | −36,032−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −26,351−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −24,973−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −24,712−100.0% | Sold out |
| Savant Capital, LLC | 0 | $0 | 0.00% | −23,893−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −22,971−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −22,713−100.0% | Sold out |
| Meriwether Wealth & Planning, LLC | 0 | $0 | 0.00% | −21,640−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −17,949−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −17,134−100.0% | Sold out |
| Vident Advisory, LLC | 0 | $0 | 0.00% | −14,735−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −14,167−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −10,412−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −7,402−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −68−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |